These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 26557005)

  • 21. The assessment and management of cirrhotic patients with encephalopathy.
    Kibble H; Shawcross DL
    United European Gastroenterol J; 2024 Mar; 12(2):187-193. PubMed ID: 38180440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on management of patients with overt hepatic encephalopathy.
    Chacko KR; Sigal SH
    Hosp Pract (1995); 2013 Aug; 41(3):48-59. PubMed ID: 23948621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Embolization of splenorenal shunt associated to portal vein thrombosis and hepatic encephalopathy.
    Franzoni Lde C; de Carvalho FC; Garzon RG; Yamashiro Fda S; Augusti L; Santos LA; Dorna Mde S; Baima JP; Lima TB; Caramori CA; Silva GF; Romeiro FG
    World J Gastroenterol; 2014 Nov; 20(42):15910-5. PubMed ID: 25400477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic encephalopathy.
    Häussinger D; Dhiman RK; Felipo V; Görg B; Jalan R; Kircheis G; Merli M; Montagnese S; Romero-Gomez M; Schnitzler A; Taylor-Robinson SD; Vilstrup H
    Nat Rev Dis Primers; 2022 Jun; 8(1):43. PubMed ID: 35739133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic encephalopathy - recent advances in treatment and diagnosis.
    Nardelli S; Gioia S; Faccioli J; Riggio O; Ridola L
    Expert Rev Gastroenterol Hepatol; 2023 Mar; 17(3):225-235. PubMed ID: 36843291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rifaximin for treatment of hepatic encephalopathy.
    Maclayton DO; Eaton-Maxwell A
    Ann Pharmacother; 2009 Jan; 43(1):77-84. PubMed ID: 19092143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The molecular pathogenesis of hepatic encephalopathy.
    Jalan R; Shawcross D; Davies N
    Int J Biochem Cell Biol; 2003 Aug; 35(8):1175-81. PubMed ID: 12757755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms, diagnosis and management of hepatic encephalopathy.
    Prakash R; Mullen KD
    Nat Rev Gastroenterol Hepatol; 2010 Sep; 7(9):515-25. PubMed ID: 20703237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy.
    Tapper EB; Jiang ZG; Patwardhan VR
    Mayo Clin Proc; 2015 May; 90(5):646-58. PubMed ID: 25865476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profile of hepatic encephalopathy in children with cirrhosis and response to lactulose.
    Sharma P; Sharma BC
    Saudi J Gastroenterol; 2011; 17(2):138-41. PubMed ID: 21372353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of sleep architecture parameters in cirrhotic patients with recurrent hepatic encephalopathy with the use of rifaximin.
    Bruyneel M; Sersté T; Libert W; van den Broecke S; Ameye L; Dachy B; Mulkay JP; Moreno C; Gustot T
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):302-308. PubMed ID: 27977438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complications of cirrhosis III. Hepatic encephalopathy.
    Butterworth RF
    J Hepatol; 2000; 32(1 Suppl):171-80. PubMed ID: 10728803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence of Helicobacter pylori in liver cirrhosis complicated with hepatic encephalopathy].
    Săndulache L; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1056-60. PubMed ID: 20191873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacotherapy for hyperammonemia.
    Hadjihambi A; Khetan V; Jalan R
    Expert Opin Pharmacother; 2014 Aug; 15(12):1685-95. PubMed ID: 25032885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic encephalopathy: a critical current review.
    Hadjihambi A; Arias N; Sheikh M; Jalan R
    Hepatol Int; 2018 Feb; 12(Suppl 1):135-147. PubMed ID: 28770516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of Hepatic Encephalopathy: A Primer.
    Jawaro T; Yang A; Dixit D; Bridgeman MB
    Ann Pharmacother; 2016 Jul; 50(7):569-77. PubMed ID: 27126547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current concepts in the assessment and treatment of hepatic encephalopathy.
    Cash WJ; McConville P; McDermott E; McCormick PA; Callender ME; McDougall NI
    QJM; 2010 Jan; 103(1):9-16. PubMed ID: 19903725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ammonia levels and the severity of hepatic encephalopathy.
    Qureshi MO; Khokhar N; Shafqat F
    J Coll Physicians Surg Pak; 2014 Mar; 24(3):160-3. PubMed ID: 24613109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.